title: Polyunsaturated fatty acids inhibit melanoma cell growth in vitro.
abstract: Human malignant melanoma is a highly aggressive and incurable cancer due to intrinsic resistance to apoptosis and reprogramming proliferation and survival pathways during progression. Numerous studies, including our own, linked arachidonic acid (AA, 20:4 n-6), eicosapentaenoic acid (EPA, 20:5 n-3), and docosahexaenoic acid (DHA, 22:6 n-3) supplementation to induction of apoptosis and decreased proliferation of various cancer cells. The cytotoxic effects result from lipid peroxidation and formation of reactive oxygen species (ROS), which modify proteins and nucleic acids. DNA damage by ROS causes mutations and genomic instability, leading to uncontrolled proliferation or cell death. In the present work, four human melanoma cell lines differing in origin, doubling time, metastatic potential, and melanin content (A375, A2058, G361, and C32) were exposed to AA, EPA or DHA added into culture media in the concentrations ranging from 0 (control) to 100 mM. After 24 h incubation cytotoxicity of the analyzed acids was determined with TOX-2 (In Vitro Toxicology Assay Kit XTT Based, TOX-2, Sigma) test. The oxidative protein modifications were measured using Aldehyde Site (DNA and Protein) Detection Kit (Cayman). All the acids tested showed marked inhibition of cell proliferation. The observed effects were statistically significant and depended on the concentration. Decrease of proliferation, associated by oxidative protein and DNA damage (measured as aldehyde sites in cells), was observed for EPA and DHA (50 mM and 100 mM) in A375, A2058, and G361 cells. In case of C32 cell line, which is amelanotic melanoma, EPA and DHA inhibited cell proliferation at 100 mM only. The effect of DHA was more pronounced. AA did not show its antiproliferative action in this cell line. The obtained results suggest that antiproliferative effects of the fatty acids in cultured human melanoma cells depend on the type of acid, its concentration and may be diverse when different melanoma cell lines are used.
authors.affiliation: Department of Biopharmacy, Medical University of Silesia, Narcyzów 1, 41-200 Sosnowiec, Poland. azajdel@sum.edu.pl
authors.forename: Alicja
authors.initials: A
authors.lastname: Zajdel
authors.forename: Adam
authors.initials: A
authors.lastname: Wilczok
authors.forename: Ewa
authors.initials: E
authors.lastname: Chodurek
authors.forename: Arkadiusz
authors.initials: A
authors.lastname: Gruchlik
authors.forename: Zofia
authors.initials: Z
authors.lastname: Dzierzewicz
mesh_terms: D000970:Antineoplastic Agents / Q000494:pharmacology*; D017209:Apoptosis / Q000187:drug effects; D045744:Cell Line, Tumor; D049109:Cell Proliferation / Q000187:drug effects*; D002470:Cell Survival / Q000187:drug effects; D004249:DNA Damage; D004281:Docosahexaenoic Acids / Q000494:pharmacology*; D004305:Dose-Response Relationship, Drug; D015118:Eicosapentaenoic Acid / Q000494:pharmacology*; D006801:Humans; D008545:Melanoma / Q000378:metabolism / Q000473:pathology*; D018384:Oxidative Stress / Q000187:drug effects; D012878:Skin Neoplasms / Q000378:metabolism / Q000473:pathology*
chemical_list: D000970:Antineoplastic Agents; D004281:Docosahexaenoic Acids; D015118:Eicosapentaenoic Acid